BG Medicine Inc - ESG Rating & Company Profile powered by AI
Scroll down to the end of this webpage for potential risks for BG Medicine Inc based on sector, geography and size. This page includes a Q&A table for BG Medicine Inc. The webpage of BG Medicine Inc is prepared by All Street Sevva using proprietary machine learning.
BG Medicine Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | BG Medicine Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does BG Medicine Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes BG Medicine Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes BG Medicine Inc report the average age of the workforce?
Sign up for free to unlockDoes BG Medicine Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes BG Medicine Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes BG Medicine Inc disclose cybersecurity risks?
Sign up for free to unlockDoes BG Medicine Inc offer flexible work?
Sign up for free to unlockDoes BG Medicine Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes BG Medicine Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes BG Medicine Inc conduct supply chain audits?
Sign up for free to unlockDoes BG Medicine Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes BG Medicine Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes BG Medicine Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes BG Medicine Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes BG Medicine Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes BG Medicine Inc disclose water use targets?
Sign up for free to unlockDoes BG Medicine Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid BG Medicine Inc have a product recall in the last two years?
Sign up for free to unlockDoes BG Medicine Inc disclose incidents of discrimination?
Sign up for free to unlockDoes BG Medicine Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas BG Medicine Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes BG Medicine Inc disclose parental leave metrics?
Sign up for free to unlockDoes BG Medicine Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes BG Medicine Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes BG Medicine Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes BG Medicine Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes BG Medicine Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes BG Medicine Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs BG Medicine Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes BG Medicine Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes BG Medicine Inc disclose its waste policy?
Sign up for free to unlockDoes BG Medicine Inc report according to TCFD requirements?
Sign up for free to unlockDoes BG Medicine Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes BG Medicine Inc disclose energy use targets?
Sign up for free to unlockDoes BG Medicine Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes BG Medicine Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for BG Medicine Inc
These potential risks are based on the size, segment and geographies of the company.
BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.